Evaluation of kidney function at ICU discharge using iohexol clearance in patients with normal serum creatinine after acute kidney injury

Acute kidney injury (AKI) is a common complication in critically ill patients and is associated with high rates of mortality or progression to chronic kidney disease, even when serum creatinine returns to normal at ICU discharge. This study aims to evaluate the frequency of non-resolving kidney dysfunction at ICU discharge despite normal serum creatinine levels following AKI, and to assess its association with chronic kidney disease at 6 months. This multicenter, observational study included patients who experienced AKI (KDIGO stage 2 or 3) during their ICU stay and had serum creatinine < 130 µmol/L (men) or <110 µmol/L (women) at discharge. Iohexol clearance and serum and urinary creatinine were measured at ICU discharge, once other organ failures had resolved. Serum creatinine was also assessed at 6 months. Non-resolving kidney dysfunction was defined as iohexol clearance < 60 mL/min/1.73 m 2 . Among 137 patients, 70 (51%) had non-resolving kidney dysfunction at ICU discharge. Among these 70 patients, urine creatinine clearance and CKD-EPI-based estimated glomerular filtration rate (GFR) were < 60 mL/min/1.73 m 2 in 69% and 19% of cases, respectively. In multivariable analysis, risk factors for non-resolving dysfunction included older age, longer ICU stay, presence of malignancy, and higher baseline and admission serum creatinine. Patients with non-resolving kidney dysfunction had significantly lower CKD-EPI GFR at 6 months compared to those with resolving dysfunction. Non-resolving kidney dysfunction was present in approximately half of patients who had experienced severe AKI despite normal serum creatinine at ICU discharge, highlighting the limitations of serum creatinine in assessing renal recovery in critically ill patients. Non-resolving dysfunction was associated with lower CKD-EPI GFR at 6 months. ClinicalTrials.gov, identifier: NCT02961478. Registered on November 11, 2016.

Authors

Institutions

Publication Details

Journal
Critical Care
Published
2026-11-18
DOI
https://doi.org/10.1186/s13054-026-06465-0
Primary Topic
Acute Kidney Injury Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Evaluation of kidney function at ICU discharge using iohexol clearance in patients with normal serum creatinine after acute kidney injury

Maxime Coutrot, Stéphan Ehrmann, Jean‐Baptiste Woillard, Jean Dellamonica et al.
Critical Care
Acute Kidney Injury Research
article

Evaluation of kidney function at ICU discharge using iohexol clearance in patients with normal serum creatinine after acute kidney injury

Maxime Coutrot, Stéphan Ehrmann, Jean‐Baptiste Woillard, Jean Dellamonica, René Robert, Sylvain Le Pape, Emmanuel Canet, Alexandre Conia, Jean-Claude Lachérade, Patrice Tirot, Isabelle Benz‐de Bretagne, François Beloncle, Charlotte Salmon Gandonnière, Alexandre Lautrette, Nicolas Lerolle, Jean François Hamel, Chantal Barin-Le Guellec
article en

Abstract

Acute kidney injury (AKI) is a common complication in critically ill patients and is associated with high rates of mortality or progression to chronic kidney disease, even when serum creatinine returns to normal at ICU discharge. This study aims to evaluate the frequency of non-resolving kidney dysfunction at ICU discharge despite normal serum creatinine levels following AKI, and to assess its association with chronic kidney disease at 6 months. This multicenter, observational study included patients who experienced AKI (KDIGO stage 2 or 3) during their ICU stay and had serum creatinine < 130 µmol/L (men) or <110 µmol/L (women) at discharge. Iohexol clearance and serum and urinary creatinine were measured at ICU discharge, once other organ failures had resolved. Serum creatinine was also assessed at 6 months. Non-resolving kidney dysfunction was defined as iohexol clearance < 60 mL/min/1.73 m 2 . Among 137 patients, 70 (51%) had non-resolving kidney dysfunction at ICU discharge. Among these 70 patients, urine creatinine clearance and CKD-EPI-based estimated glomerular filtration rate (GFR) were < 60 mL/min/1.73 m 2 in 69% and 19% of cases, respectively. In multivariable analysis, risk factors for non-resolving dysfunction included older age, longer ICU stay, presence of malignancy, and higher baseline and admission serum creatinine. Patients with non-resolving kidney dysfunction had significantly lower CKD-EPI GFR at 6 months compared to those with resolving dysfunction. Non-resolving kidney dysfunction was present in approximately half of patients who had experienced severe AKI despite normal serum creatinine at ICU discharge, highlighting the limitations of serum creatinine in assessing renal recovery in critically ill patients. Non-resolving dysfunction was associated with lower CKD-EPI GFR at 6 months. ClinicalTrials.gov, identifier: NCT02961478. Registered on November 11, 2016.

Critical Care
Université de Tours (FR), Inserm (FR), Université Côte d'Azur (FR), Centre Hospitalier Universitaire de Nice (FR), Centre Hospitalier Universitaire de Nantes (FR), Université de Poitiers (FR), Institut de Chimie de Nice (FR), Imaging, Brain, and Neuropsychiatry (FR), Centre Hospitalier Universitaire de Tours (FR), Clinical Investigation Center Plurithematic Tours (FR), Institut de Recherche en Santé, Environnement et Travail (FR), Centre Hospitalier Universitaire de Poitiers (FR), Centre Hospitalier Universitaire d'Angers (FR), Les Hôpitaux de Chartres (FR), Centre Hospitalier Universitaire de Limoges (FR), Centre Jean Perrin (FR), Centre Hospitalier Universitaire de Clermont-Ferrand (FR), Hôpital Saint-Louis (FR), Centre Hospitalier Départemental Vendée (FR), Pharmacologie & Transplantation (FR), Unité de Recherche Clinique Côte d'Azur (FR), Marqueurs cardiovasculaires en situation de stress (FR), Université d'Angers (FR), Université de Limoges (FR), Nantes Université (FR)
Good health and well-being
Acute Kidney Injury Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon